Topic: Prostate cancer.
Destination: The PCRP has developed a strategic plan that outlines the program’s approach for addressing critical gaps in prostate cancer research and patient care. Currently, the PCRP seeks to address the following Overarching Challenges:
• Improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancer
• Develop treatments that improve outcomes for men with lethal prostate cancer
• Advance health equity and reduce disparities in prostate cancer
• Define the biology of lethal prostate cancer to reduce death.
Seven awards are available:
• Exploration – Hypothesis Development Award (EHDA)
• Early Investigator Research Award (EIRA)
• Physician Research Award (PRA)
• Translational Science Award (TSA)
• Health Disparity Research Award (HDRA)
• Idea Development Award (IDA)
• Data Science Award (DSA)
Budget: 100.000-750.000 USD, depending on the award mechanism.
Duration: 2-4 years.
Deadline:
• Exploration – Hypothesis Development Award (EHDA): June 2, 2022.
• Early Investigator Research Award (EIRA): July 7, 2022.
• Physician Research Award (PRA): July 7, 2022.
• Translational Science Award (TSA): August 4, 2022.
• Health Disparity Research Award (HDRA): August 4, 2022.
• Idea Development Award (IDA): July 7, 2022.
• Data Science Award (DSA): August 4, 2022.
Llena el siguiente formulario para recibir más información: